08:00 , Mar 8, 2004 |  BC Week In Review  |  Company News

CatchMabs, Exponential Biotherapies Inc. deal

The companies partnered to produce bacteriophages that kill specific bacteria in food and water. The deal combines CatchMabs' affinity protein production technology with Exponential's bacteriophage capabilities. CatchMabs B.V. , Wageningen, the Netherlands   Exponential Biotherapies...